drugset / Trial / NCT03061045

Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus

NCT03061045

Phase 4 Withdrawn Johns Hopkins University
NaSingle-groupOpen-labelDiagnostic

Summary

The aim of the proposed project is therefore to utilize the CEUS technique to assess cerebral perfusion changes before and after ventricular shunting in neonatal cases of PHH. The expectation of the proposed project is to validate statistically significant cerebral perfusion differences before and after shunting in neonates with PHH, as a preliminary feasibility study prior to conducting a large scale, prospective clinical trial incorporating therapeutic interventions using the CEUS technique.

Timeline

Start
2017-04-01
Primary completion
2018-01-22
Completion
2018-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 25 mg Intravenous

Indications